共 576 条
- [1] Dezfouli S(2005)Use of cytokines in cancer vaccines/ immunotherapy: recent developments improve survival rates for patients with metastatic malignancy Curr Pharm Des 11 3511-30
- [2] Hatzinisiriou I(2005)Melanoma vaccines: what we know so far Oncology (Williston Park) 19 97-108
- [3] Ralph SJ(2006)The treatment of melanoma with an emphasis on immunotherapeutic strategies Surg Oncol 15 13-24
- [4] Bystryn JC(2006)Evaluation of immunotherapy in the treatment of melanoma Surg Oncol Clin N Am 15 399-418
- [5] Reynolds SR(2006)Strategies for the development of more effective adjuvant therapy of melanoma: current and future explorations of antibodies, cytokines, vaccines, and combinations Clin Cancer Res 12 2331-6
- [6] Jack A(2006)Allogeneic and autologous melanoma vaccines: where have we been and where are we going Clin Cancer Res 12 2337-41
- [7] Boyes C(2006)Update on immunotherapy for melanoma J Natl Compr Canc Netw 7 687-94
- [8] Aydin N(2004)Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes Proc Natl Acad Sci U S A 101 14639-45
- [9] Faries MB(2005)Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma J Clin Oncol 23 2346-57
- [10] Kirkwood JM(2006)Adoptive immunotherapy for cancer: building on success Nat Rev Immunol 6 383-93